Codiak Biosciences Inc 's ROA from the third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Codiak Biosciences Inc 's ROA in the third quarter of 2022?
Codiak Biosciences Inc recorded a cumulative net loss of $-17 million during 12 months ending in the third quarter of 2022, resulting in a negative return on assets (ROA) of -14.18%.

However, within the Healthcare sector 339 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2022 quarter, so far to 3919, from total ROA ranking in the second quarter of 2022 at 4123.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Total Assets Change	-16.9 %	-28.09 %	-23.67 %	14.87 %	20.79 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-17	-20	-35	-37	-72
Return On Assets (TTM)	-14.18 %	-15.45 %	-25.1 %	-24.98 %	-49.84 %
CDAK's Total Ranking	# 3919	# 4123	# 4381	# 4670	# 4290
Total Assets (TTM) in million	111	108	126	147	133
Seq. Total Assets Change	2.98 %	-14.88 %	-13.83 %	10.02 %	-10.89 %
Seq. Net Income Change	-	-	-	-	-

CDAK's 5 Years Annual ROA >> Back to CDAK Management Effectiveness >> Compare CDAK ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 35
Sector	# 340
Overall	# 3838

Return On Assets Statistics
High	Average	Low
-11.83 %	-21.71 %	-42.42 %
(Sep 30 2022)		(Sep 30 2021)

Financial Statements
Codiak Biosciences Inc 's Assets	$ 111 million	CDAK's Balance sheet
Codiak Biosciences Inc 's Income	$ -19 million	Quarterly CDAK's Income Statement
CDAK's Income by Division		See CDAK's Income by Division

Annual Return On Assets	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	FY	FY	FY
Y / Y Total Assets Change	17.16 %	-	-	-	-
Total Assets in million	147	125	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-37	-92	0	0	0
Annual Return On Assets	-25.34 %	-73.23 %	-	-	-

CDAK's 5 Years Annual ROA >> Back to CDAK Management Effectiveness >> Compare CDAK ROA to its Competitors

More Return On Assets Ratios
CDAK's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CDAK's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CDAK's Competitors
Subscribers only: Roa for Codiak Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for CDAK's Customers

You may also want to know
CDAK's Roi	CDAK's Inventory Turnover Ratio	CDAK's Growth Rates	CDAK's Dividend Comparisons
	CDAK's Profitability Ratios	CDAK's Asset Turnover Ratio	CDAK's Dividend Growth
CDAK's Roe	CDAK's Valuation Ratios	CDAK's Financial Strength Ratios	CDAK's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2022, within Healthcare Sector

ROA

Date modified: 2026-09-26T07:39:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.